title: Dopamine D3 receptor dysfunction prevents anti-nociceptive effects of morphine in the spinal cord.
abstract: Dopamine (DA) modulates spinal reflexes, including nociceptive reflexes, in part via the D3 receptor subtype. We have previously shown that mice lacking the functional D3 receptor (D3KO) exhibit decreased paw withdrawal latencies from painful thermal stimuli. Altering the DA system in the CNS, including D1 and D3 receptor systems, reduces the ability of opioids to provide analgesia. Here, we tested if the increased pain sensitivity in D3KO might result from a modified μ-opioid receptor (MOR) function at the spinal cord level. As D1 and D3 receptor subtypes have competing cellular effects and can form heterodimers, we tested if the changes in MOR function may be mediated in D3KO through the functionally intact D1 receptor system. We assessed thermal paw withdrawal latencies in D3KO and wild type (WT) mice before and after systemic treatment with morphine, determined MOR and phosphorylated MOR (p-MOR) protein expression levels in lumbar spinal cords, and tested the functional effects of DA and MOR receptor agonists in the isolated spinal cord. In vivo, a single morphine administration (2 mg/kg) increased withdrawal latencies in WT but not D3KO, and these differential effects were mimicked in vitro, where morphine modulated spinal reflex amplitudes (SRAs) in WT but not D3KO. Total MOR protein expression levels were similar between WT and D3KO, but the ratio of pMOR/total MOR was higher in D3KO. Blocking D3 receptors in the isolated WT cord precluded morphine's inhibitory effects observed under control conditions. Lastly, we observed an increase in D1 receptor protein expression in the lumbar spinal cord of D3KO. Our data suggest that the D3 receptor modulates the MOR system in the spinal cord, and that a dysfunction of the D3 receptor can induce a morphine-resistant state. We propose that the D3KO mouse may serve as a model to study the onset of morphine resistance at the spinal cord level, the primary processing site of the nociceptive pathway.
authors: Department of Physiology, Brody School of Medicine, East Carolina University Greenville, NC, USA.
authors: Kori L
authors: KL
authors: Brewer
authors: Department of Emergency Medicine, Brody School of Medicine, East Carolina University Greenville, NC, USA.
authors: Christine A
authors: CA
authors: Baran
authors: Department of Emergency Medicine, Brody School of Medicine, East Carolina University Greenville, NC, USA.
authors: Brian R
authors: BR
authors: Whitfield
authors: Department of Physiology, Brody School of Medicine, East Carolina University Greenville, NC, USA.
authors: A Marley
authors: AM
authors: Jensen
authors: Department of Physiology, Brody School of Medicine, East Carolina University Greenville, NC, USA.
authors: Stefan
authors: S
authors: Clemens
mesh_terms: D000818:Animals; D008297:Male; D051379:Mice; D018345:Mice, Knockout; D009020:Morphine / Q000494:pharmacology*; D009294:Narcotics / Q000494:pharmacology*; D059225:Nociception / Q000187:drug effects / Q000502:physiology*; D017288:Pain Threshold / Q000187:drug effects; D010766:Phosphorylation; D050637:Receptors, Dopamine D3 / Q000235:genetics / Q000378:metabolism*; D017450:Receptors, Opioid, mu / Q000819:agonists / Q000378:metabolism*; D012018:Reflex / Q000187:drug effects; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*
chemical_list: D009294:Narcotics; D050637:Receptors, Dopamine D3; D017450:Receptors, Opioid, mu; D009020:Morphine
keywords: dopamine d1 recptor; dopamine d3 receptor; mu-opiod receptor; nociception; second messenger cross-talk; spinal reflexes